Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Safety and tolerability of brimonidine purite 0.1% and brimonidine purite 0.15%: a meta-analysis of two phase 3 studies.

Cantor LB, Liu CC, Batoosingh AL, Hollander DA.

Curr Med Res Opin. 2009 Jul;25(7):1615-20. doi: 10.1185/03007990902997655.

PMID:
19469697
2.

Brimonidine-purite 0.1% versus brimonidine-purite 0.15% twice daily in glaucoma or ocular hypertension: a 12-month randomized trial.

Cantor LB, Safyan E, Liu CC, Batoosingh AL.

Curr Med Res Opin. 2008 Jul;24(7):2035-43. doi: 10.1185/03007990802199287 .

PMID:
18534052
4.

Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.

Nixon DR, Yan DB, Chartrand JP, Piemontesi RL, Simonyi S, Hollander DA.

Curr Med Res Opin. 2009 Jul;25(7):1645-53. doi: 10.1185/03007990902994041.

PMID:
19476406
5.

Brimonidine purite 0.1% versus brinzolamide 1% as adjunctive therapy to latanoprost in patients with glaucoma or ocular hypertension.

Day DG, Hollander DA.

Curr Med Res Opin. 2008 May;24(5):1435-42. doi: 10.1185/030079908X301848 .

PMID:
18402717
6.
7.

Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.

Sall KN, Greff LJ, Johnson-Pratt LR, DeLucca PT, Polis AB, Kolodny AH, Fletcher CA, Cassel DA, Boyle DR, Skobieranda F.

Ophthalmology. 2003 Mar;110(3):615-24.

PMID:
12623832
9.
11.

Latanoprost or brimonidine as treatment for elevated intraocular pressure: multicenter trial in the United States.

Camras CB, Sheu WP; United States Latanoprost-Brimonidine Study Group..

J Glaucoma. 2005 Apr;14(2):161-7.

PMID:
15741820
12.
13.
17.

Evaluation of the comfort of Alphagan P compared with Alphagan in irritated eyes.

Mundorf T, Wilcox KA, Ousler GW 3rd, Welch D, Abelson MB.

Adv Ther. 2003 Nov-Dec;20(6):329-36.

PMID:
15058750
18.

Comparison of the safety and efficacy of dorzolamide 2% and brimonidine 0.2% in patients with glaucoma or ocular hypertension.

Whitson JT, Henry C, Hughes B, Lee DA, Terry S, Fechtner RD.

J Glaucoma. 2004 Apr;13(2):168-73.

PMID:
15097265
20.

Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure.

Stewart WC, Sharpe ED, Harbin TS Jr, Pastor SA, Day DG, Holmes KT, Stewart JA.

Am J Ophthalmol. 2000 Jun;129(6):723-7.

PMID:
10926979
Items per page

Supplemental Content

Support Center